4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001209191-23-005996
CFO & COO sold 3,596 shares at $3.92 ($14,096)
From the SEC's structured data for this filing
Trades in this filing
GRAY MICHAEL · CFO & COO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-30 | Sale : show line 1 in the form | −3,596 | $3.92 | $14,096 | 37,466 | D |
| Open-market sales · 3,596 sh · avg $3.92 · $14,096 | ||||||
Loading xslF345X03/doc4.xml…